Five-year survival analysis and predictors of mortality of adult hemodialysis patients in Indonesia: a nationwide database analysis.

IF 1.8 4区 医学 Q3 UROLOGY & NEPHROLOGY
International Urology and Nephrology Pub Date : 2024-11-01 Epub Date: 2024-06-19 DOI:10.1007/s11255-024-04118-1
Metalia Puspitasari, Afiatin, Vicka Oktaria, Yulia Wardhani, Wynne Wijaya
{"title":"Five-year survival analysis and predictors of mortality of adult hemodialysis patients in Indonesia: a nationwide database analysis.","authors":"Metalia Puspitasari, Afiatin, Vicka Oktaria, Yulia Wardhani, Wynne Wijaya","doi":"10.1007/s11255-024-04118-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hemodialysis (HD) is the modality of renal replacement therapy (RRT) with the highest mortality rate. The identification of prognostic factors will help achieve better outcomes among HD patients. In this study, we sought to conduct a survival analysis and determine the predictors of mortality among adult Indonesian HD patients using data obtained from Indonesian Renal Registry (IRR).</p><p><strong>Methods: </strong>This is a retrospective cohort study which reviewed all adult hemodialysis patients in Indonesia based on the records of IRR during 2007-2022. Variables analyzed in this study include age, sex, etiology of CKD, cause of death, HD frequency, and initial vascular access. A 5-year follow-up was performed until the outcome of death or drop out was found.</p><p><strong>Results: </strong>Among 99,552 eligible patients, the mean survival length was 1536.21 ± 2.50 days. The 5-year survival rate was 77%. Cox proportional hazard regression model revealed demographic and clinical characteristics that are significantly associated with mortality: male sex (HR: 1.038, 95% CI 1.002-1.075), age of 60 years or older (HR: 1.329, 95% CI 1.281-1.379), diabetic nephropathy (HR: 1.347, 95% CI 1.249-1.452), twice-weekly hemodialysis frequency (HR: 1.080, 95% CI 1.011-1.155), initial vascular accesses with femoral vein puncture (HR: 2.710, 95% CI 2.568-2.860), and CVC (HR: 2.992, 95% CI 2.848-3.144).</p><p><strong>Conclusions: </strong>The 5-year survival rate of Indonesian HD patients is 77. Male sex, age of HD onset at 60 years or older, diabetic nephropathy, twice-weekly HD frequency, and the initial vascular accesses with femoral vein puncture and CVC are associated with increased risk of mortality.</p>","PeriodicalId":14454,"journal":{"name":"International Urology and Nephrology","volume":" ","pages":"3657-3664"},"PeriodicalIF":1.8000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Urology and Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11255-024-04118-1","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/19 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Hemodialysis (HD) is the modality of renal replacement therapy (RRT) with the highest mortality rate. The identification of prognostic factors will help achieve better outcomes among HD patients. In this study, we sought to conduct a survival analysis and determine the predictors of mortality among adult Indonesian HD patients using data obtained from Indonesian Renal Registry (IRR).

Methods: This is a retrospective cohort study which reviewed all adult hemodialysis patients in Indonesia based on the records of IRR during 2007-2022. Variables analyzed in this study include age, sex, etiology of CKD, cause of death, HD frequency, and initial vascular access. A 5-year follow-up was performed until the outcome of death or drop out was found.

Results: Among 99,552 eligible patients, the mean survival length was 1536.21 ± 2.50 days. The 5-year survival rate was 77%. Cox proportional hazard regression model revealed demographic and clinical characteristics that are significantly associated with mortality: male sex (HR: 1.038, 95% CI 1.002-1.075), age of 60 years or older (HR: 1.329, 95% CI 1.281-1.379), diabetic nephropathy (HR: 1.347, 95% CI 1.249-1.452), twice-weekly hemodialysis frequency (HR: 1.080, 95% CI 1.011-1.155), initial vascular accesses with femoral vein puncture (HR: 2.710, 95% CI 2.568-2.860), and CVC (HR: 2.992, 95% CI 2.848-3.144).

Conclusions: The 5-year survival rate of Indonesian HD patients is 77. Male sex, age of HD onset at 60 years or older, diabetic nephropathy, twice-weekly HD frequency, and the initial vascular accesses with femoral vein puncture and CVC are associated with increased risk of mortality.

Abstract Image

印度尼西亚成年血液透析患者的五年生存分析和死亡率预测因素:全国数据库分析。
背景:血液透析(HD)是死亡率最高的肾脏替代治疗(RRT)方式。确定预后因素将有助于改善血液透析患者的预后。在这项研究中,我们试图利用从印度尼西亚肾脏登记处(IRR)获得的数据,对印度尼西亚成年血液透析患者进行生存分析,并确定预测死亡率的因素:这是一项回顾性队列研究,根据 IRR 在 2007-2022 年间的记录,对印尼所有成年血液透析患者进行了回顾。研究分析的变量包括年龄、性别、慢性肾脏病病因、死亡原因、血液透析频率和初始血管通路。研究人员进行了为期 5 年的随访,直至发现死亡或退出的结果:结果:在 99,552 名符合条件的患者中,平均存活时间为(1536.21 ± 2.50)天。5年生存率为77%。Cox 比例危险回归模型显示了与死亡率显著相关的人口统计学和临床特征:男性(HR:1.038,95% CI 1.002-1.075)、60 岁或以上(HR:1.329,95% CI 1.281-1.379)、糖尿病肾病(HR:1.038,95% CI 1.002-1.075)、糖尿病肾病(HR:1.329,95% CI 1.281-1.379)。379)、糖尿病肾病(HR:1.347,95% CI 1.249-1.452)、每周两次血液透析频率(HR:1.080,95% CI 1.011-1.155)、初始血管通路为股静脉穿刺(HR:2.710,95% CI 2.568-2.860)和CVC(HR:2.992,95% CI 2.848-3.144):印度尼西亚 HD 患者的 5 年生存率为 77%。男性性别、60 岁或以上的 HD 发病年龄、糖尿病肾病、每周两次的 HD 频率以及股静脉穿刺和 CVC 的初始血管通路与死亡率风险增加有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
International Urology and Nephrology
International Urology and Nephrology 医学-泌尿学与肾脏学
CiteScore
3.40
自引率
5.00%
发文量
329
审稿时长
1.7 months
期刊介绍: International Urology and Nephrology publishes original papers on a broad range of topics in urology, nephrology and andrology. The journal integrates papers originating from clinical practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信